Table 2.
Self-reported drug use ever and in month prior to NHSDA interview by gender and genders of sexual partners in past year
| Life-time use |
Use in prior month |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men |
Women |
Men |
Women |
|||||||||||||
| Any male partners | Female partners only | Any female partners | Male partners only | Any male partners | Female partners only | Any female partners | Male partners only | |||||||||
| Drug class | % | (SE) | % | (SE) | % | (SE) | % | (SE) | % | (SE) | % | (SE) | % | (SE) | % | (SE) |
| Marijuana | 64.6 | (8.8) | 52.3 | (1.3) | 75.8* | (5.8) | 39.6 | (11.6) | 3.9 | (4.8) | 8.4 | (0.5) | 14.0* | (4.7) | 3.4 | (0.3) |
| Cocaine | 37.2* | (6.8) | 19.5 | (0.9) | 38.5* | (8.8) | 12.1 | (0.7) | 3.9* | (2.0) | 1.2 | (0.2) | 1.7 | (1.0) | 0.6 | (0.1) |
| Hallucinogens | 34.7* | (7.5) | 18.0 | (1.1) | 22.9* | (6.0) | 9.9 | (0.7) | 1.6 | (1.2) | 0.7 | (0.1) | 1.4 | (1.0) | 0.3 | (0.1) |
| Heroin | 4.1 | (2.0) | 2.2 | (0.4) | 2.8 | (1.6) | 0.9 | (0.2) | 0.8 | (0.8) | 0.1 | (0.1) | 0.0 | (0.0) | 0.0 | (0.0) |
| Inhalants | 30.8* | (6.0) | 9.8 | (0.8) | 14.3* | (5.4) | 5.0 | (0.5) | 0.0 | (0.0) | 0.6 | (0.2) | 0.0 | (0.0) | 0.1 | (0.0) |
| Sedatives | 9.0 | (4.1) | 4.0 | (0.5) | 7.9* | (4.5) | 1.9 | (0.3) | 0.0 | (0.0) | 0.1 | (0.0) | 1.0 | (1.0) | 0.2 | (0.1) |
| Stimulants | 14.4 | (5.1) | 7.3 | (0.7) | 12.5* | (4.5) | 5.3 | (0.5) | 0.7 | (0.7) | 0.9 | (0.2) | 1.1 | (1.1) | 0.5 | (0.1) |
| Analgesics | 15.9* | (5.5) | 7.9 | (0.6) | 6.6 | (2.3) | 5.7 | (0.5) | 0.0 | (0.0) | 1.0 | (0.2) | 3.3* | (1.7) | 0.5 | (0.1) |
| Tranquilizers | 13.9* | (4.3) | 5.4 | (0.5) | 7.4 | (3.1) | 3.7 | (0.4) | 0.4 | (0.4) | 0.6 | (0.2) | 1.0 | (1.0) | 0.4 | (0.1) |
| Any drug class | 72.8* | (8.2) | 54.6 | (1.2) | 77.9* | (5.6) | 42.3 | (1.1) | 16.3 | (5.0) | 9.9 | (0.6) | 15.1* | (4.8) | 4.5 | (0.4) |
Percentages are estimated using sampling weights. Unweighted sample sizes are for homosexually active men (n = 98) and women (n = 96) and hetenosexually active men (n = 3922) and women (n = 5792).
*
P < 0.05, when sexual orientation effect evaluated by logistic regression analyses conducted on each gender separately while adjusting for possible demographic confounding.